Please login to the form below

Not currently logged in
Email:
Password:

Pharmaceutical

This page shows the latest Pharmaceutical news and features for those working in and with pharma, biotech and healthcare.

Rigel and Ultragenyx claim approvals for rare drugs

Rigel and Ultragenyx claim approvals for rare drugs

The FDA gave the go-ahead to a pair of rare disease therapies this week, both marking the first-ever approvals for developers Rigel Pharmaceuticals and Ultragenyx.

Latest news

More from news
Approximately 81 fully matching, plus 1,131 partially matching documents found.

Latest Intelligence

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    have dropped by over a half in the past decade. Moreover, many innovative pharmaceutical companies have pulled out of antibiotics research due to negative returns on investment in R&D and

  • Brexit Means Brexit Brexit Means Brexit

    Brexit may indeed mean Brexit - but for the European pharmaceutical industry, knowing what it really means is hugely important. ... These common-sense ambitions are broadly aligned with those of EFPIA and pharmaceutical companies across Europe.

  • The challenges of making genomics a reality for patients The challenges of making genomics a reality for patients

    The appraisal system in the UK needs to reflect that specific genes and pathways underlying genetic diseases seldom respond to traditional pharmaceutical approaches and so precision medicine requires risk-taking innovation.

  • A critical juncture for clinical data management A critical juncture for clinical data management

    pharmaceutical companies and contract research organisations (CROs).

  • A new era of smart pharma A new era of smart pharma

    A new era of smart pharma. How smarter pharmaceuticals and pharmacovigilance are transforming healthcare. ... The pharmaceutical industry is undergoing an evolution as new technologies disrupt the industry.

More from intelligence
Approximately 2 fully matching, plus 534 partially matching documents found.

Latest appointments

  • Sobi poaches Pfizer’s Fredrick Wetterlundh Sobi poaches Pfizer’s Fredrick Wetterlundh

    Guido Oelkers, CEO and president of Sobi, said: “His experience from the pharmaceutical industry, numerous company integrations and the global roles he has held will be of great value for Sobi,

  • Targovax strengthens board of directors Targovax strengthens board of directors

    Targovax strengthens board of directors. Catherine Wheeler joins from Acetylon Pharmaceutical. ... Most recently, Wheeler served Acetylon Pharmaceutical as chief medical officer and prior to that she held progressively senior clinical and business

  • Dermavant strengthens executive team Dermavant strengthens executive team

    He has previously served as chief financial officer for Novan and chief financial officer, executive vice president of Medicis Pharmaceutical Corporation.

  • Neurocentrx appoints two members to the board Neurocentrx appoints two members to the board

    Neurocentrx, a UK-based pharmaceutical company, has appointed Nigel Brooksby (pictured right) as non-executive chairman.

  • Novo Nordisk appoints new general manager Novo Nordisk appoints new general manager

    Sahota started his pharmaceutical career in sales and marketing with companies which formed Sanofi Aventis, before moving to SmithKline Beecham - now GlaxoSmithKline - where he held a number of commercial leadership roles

More from appointments
Approximately 54 fully matching, plus 673 partially matching documents found.

Latest from PMHub

  • OPEN Access Consulting

    OAC have significant experience in the development of strategic solutions to enable pharmaceutical companies to support budget holders and reimbursement stakeholders in adopting new technologies at Global, European and UK level.

  • ECHO Medical Communications

    ECHO supports pharmaceutical companies and healthcare providers from strategic development to the delivery and implementation of your scientific message. ... ECHO has distilled decades of experience to bring you unique and inspiring solutions by

  • ECHO Medical Communications

    ECHO supports pharmaceutical companies and healthcare providers from strategic development to the delivery and implementation of your scientific message. ... ECHO has distilled decades of experience to bring you unique and inspiring solutions by

  • Unique forum will unite NHS and industry to drive innovation

    Another key speaker will be Steve Oldfield, the Department of Health and Social Care’ s chief commercial officer and the person charged with renegotiating the £8bn pharmaceutical pricing regulation scheme, who

  • Novasecta

    Novasecta. Novasecta is Europe's leading pharmaceutical strategy consultancy. We work with CEO's, COO's and senior leaders to address their biggest strategic challenges.

More from PMHub
Approximately 31 fully matching, plus 753 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Media

Four Health Media creates world class integrated media solutions with global reach, deep insight, innovative methods and a highly personal...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics